Gabapentin and Meningism - a phase IV clinical study of FDA data

Summary:

Meningism is reported as a side effect among people who take Gabapentin (gabapentin), especially for people who are female, 50-59 old, also take Pantoprazole, and have Chronic inflammatory demyelinating polyradiculoneuropathy.

The phase IV clinical study analyzes which people have Meningism when taking Gabapentin. It is created by eHealthMe based on reports of 313,421 people who have side effects when taking Gabapentin from the FDA, and is updated regularly.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 322,987 Gabapentin users. Check the latest studies of Gabapentin.

What is Meningism?

Meningism (the triad of nuchal rigidity (neck stiffness), photophobia (intolerance of bright light) and headache. it is a sign of irritation of the meninges) is found to be associated with 91 drugs and 252 conditions by eHealthMe. Check the latest studies of Meningism.

On Jul, 31, 2026

313,421 people reported to have side effects when taking Gabapentin.
Among them, 11 people (0.0%) have Meningism.

Among these 11 people:

What is the gender of people who have Meningism when taking Gabapentin? *

female: 80 %
male: 20 %

What is the age of people who have Meningism when taking Gabapentin? *

What are other drugs people take besides Gabapentin? *

What are other side effects people have besides Meningism? *

Fever: 5 people, 45.45%
Dyspnea (difficult or laboured breathing): 5 people, 45.45%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 4 people, 36.36%
Meningitis Aseptic (a condition that causes the membranes covering your brain and spinal cord to become inflamed): 4 people, 36.36%
Stress And Anxiety: 4 people, 36.36%
Movement - Uncoordinated: 4 people, 36.36%
Fatigue (feeling of tiredness): 4 people, 36.36%
Weakness: 4 people, 36.36%
Coordination Abnormal (abnormal movement): 3 people, 27.27%
Mental Impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition): 3 people, 27.27%

What are the existing conditions these people have? *

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (long lasting infection of nerves outside brain and spinal cord): 3 people, 27.27%
Muscle Spasms (muscle contraction): 2 people, 18.18%
Macular Oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken): 2 people, 18.18%
Laxative Supportive Care: 2 people, 18.18%
Drowsiness: 2 people, 18.18%
Constipation: 2 people, 18.18%
Breast Cancer: 2 people, 18.18%
Klebsiella Sepsis (klebsiella causes a potentially fatal whole-body inflammation): 1 person, 9.09%
Depression: 1 person, 9.09%
Back Pain: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Gabapentin and have Meningism?

- Check whether Meningism is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gabapentin:

Gabapentin (322,987 reports)

Meningism treatments and more:

Meningism (838 reports)

Browse all side effects of Gabapentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Meningism:

Meningism (91 drugs)

Browse all the conditions that are associated with Meningism:

Meningism (252 conditions)

Related publications that referenced our studies

de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on gabapentin (the active ingredients of Gabapentin) and Gabapentin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.